Older children especially from seven to thirteen years old are more prone to develop 12 Mycoplasma pneumoniae (MP) infection; in winter children are more susceptible to infect 13 with MP. In Beijing, China in 2016 the rates of macrolide resistance of MP were 69.48% (in 14 total children), 61.59% (in outpatients) and 79.28% (in hospitalized patients), respectively. 15
. Our previous study found 25 that 46 clinical isolates collected from 2003 to 2006 were MRMP, the rate of macrolide resistance 26 was as high as 92% in Beijing 3 . Macrolide resistance rates were 3.5 -13.2% in USA [4] [5] , below 10% 27 in Europe 6 , 50-90% in Japan [7] [8] and more than 90% in China 3,9-10 . 28
Tanaka et al found that the prevalence of macrolide-resistant MP gradually declined during 29 2013-2015 11 . In China few studies about macrolide-resistant were reported since 2015, this study 30 was scheduled to investigate the epidemiology and macrolide resistance rate of pediatric patients 31 with MP infection in Beijing in 2016. 32
MATERIALS AND METHODS 33
M. pneumoniae strains. A total of 619 pediatric patients suspected as MP infection at seven 34 hospitals in Beijing (China Meitan General Hospital, Civil Activation General Hospital, Beijing 35
Changping Hospital of Integrated Chinese and Western Medicine, Peking University Third 36
Hospital, Beijing Chao-Yang Hospital, New Century International Children′s Hospital, and 37
Beijing Friendship Hospital) were enrolled in the study. During January 2016 to December 2016, 38 patients aged from 1 month to 14 years, had a preceding fever, cough or pharyngalgia whose 39 onset time was from 1 to 7 days were eligible for enrollment. Throat swabs or BALF were 40 obtained in 24h after their enrollment. 41
Positive result for culture or DNA detection by real-time PCR from throat swabs or BALF was 42 considered as MP infection. For MP culture, clinical specimens were vortexed, supplemented with 43 amphotericin B and penicillin, and inoculated into SP-4 medium. The medium was incubated at 44 37°C, and observed daily for 2-6 weeks for a decrease in pH (a red to yellow color change). Then 45 the positive specimens for MP culture were identified using a real-time PCR 12 . DNA of MP in 46 throat swabs or BALF was extracted using a QIAmp DNA Mini Kit (Qiagen, Hilden, 47 Germany).Then, the above real-time PCR was done to detect DNA of MP. 48
Detection of the mutations associated with macrolide resistance of MP. Macrolide resistance 49 associated mutations in domain V of the 23S rRNA gene were detected using a direct sequencing 50 method as previously reported 13 . The amplification product of each MP strain, including the 51 reference strain M129 (ATCC 29342 ) was sequenced by the Invitrogen Biotechnology Co., Ltd. 52
Antimicrobial susceptibility testing. The minimum inhibitory concentrations (MICs) of five 53 macrolides (erythromycin, azithromycin, levofloxacin, tetracycline and josamycin) for MP strains 54 were determined by broth microdilution methods with SP4 broth (Remel). MP reference strain 55 M129 was tested as an antibiotic-sensitive control. Susceptibility tests were performed in 56 triplicate. 57
Statistical analysis. All data was expressed as means and standard deviations, unless otherwise 58 indicated. Differences in categorical variables were assessed with the χ2 test or Fisher's exact test. 59
All analyses were performed using SPSS for Windows, version 17.0 software (SPSS Inc., Chicago,
RESULTS

62
Epidemiology of pediatric patients with MP infection. A total of 262 (42.33%) pediatric 63 patients were diagnosed as MP infection by culture or DNA detection of MP. Among the 238 64 patients with MP infection marked with age, the age ranged from 1.5 months to 14 years with a 65 median of 5.67 years, Fifty-seven (23.95%) cases were 0-3 years, 71 (29.83%) were 4-6 years and 66 110 (46.22%) were 7 -13 years. The detection rates of MP infection in the above different age 67 groups were 52.38%, 34.13% and 34.13%, respectively. The incidence of MP infection increased 68 with age. The prevalence of MP infection in patients aged 7-13 especially 7-9 years was 69 significantly higher than those in the other two groups (P< .001).Among the 246 patients with MP 70 infection marked with sex, male cases are 123, female cases are 123, the ratio of male to female 71 A2063G mutation except BS315 strain showed a high resistance to erythromycin (64 92 to>256μg/ml). The erythromycin-resistant strains showed cross-resistance to azithromycin and 93 josamycin. The MIC of azithromycin (10 isolates with MIC 90 value of 32μg/ml) was lower than 94 that of erythromycin. The MIC of josamycin was the lowest (2 to 8μg/ml) in the three macrolides. 95
The MIC 90 values of BS315 strain to erythromycin, azithromycin and josamycin were 8μg/ml, 96 16μg/ml and 4μg/ml, respectively. 97
All the selected MP clinical isolates as well as the MP reference strain M129 were susceptible to 98 levofloxacin and tetracycline. Levofloxacin and tetracycline showed similar MIC 90 distribution for 99 MP, the range of MIC 90 values of levofloxacin and tetracycline were between 0.125 and 1μg/ml 100 (Table 2) . 101
DISCUSSION 102
To our knowledge, this is the first study about the evaluation of macrolide -resistance rate in 103 pediatric outpatients with MP infection in Beijing, China. The fact of high prevalence of MRMP 104 clinical isolates in pediatric patients in China mostly come from the data of hospitalized patients. 105
Outpatients are not easily achievable as many MP infections such as mild tracheobronchitis are 106 often undiagnosed, the macrolide resistance rate of MP in outpatients especially in pediatric 107 outpatients is still unclear. To investigate this and monitor the situation of macrolide resistance in 108 pediatric patients with MP infection, the present study was designed. 109
The infection rate of MP was 42.33% (262/619) in pediatric patients with respiratory infections in 110 the present study. The infection of MP is related to age and season. The infection of MP was 111 mainly prevalent in 7-13 especially 7-9 years old pediatric patients in the present study, which was 112 in accordance with the previous conclusion that the main burden of the infection is typically in 113 preschool and school-age children [14] [15] .Moreover, the prevalence of MP infection in patients aged 114 7-13 was significantly higher than those in the other two groups (P< .001) in our study. The peak 115 season of MP infection was winter in our study, and there was seasonal difference for the 116 prevalence of MP infection, it was higher during winter than that in spring (P< .05). These 117 findings were consistent with the reports that the epidemic seasons in north of China is winter but 118 is summer and autumn in the south of China 8, 16 . 119 . The decrease of high 130 rate of macrolide resistance might be partially attributable to the inclusion of pediatric outpatients. 131
The macrolide resistance rate in pediatric outpatients with MP infection was only 61.59%. This is 132 the first report about the evaluation of macrolide resistance rate in pediatric outpatients with MP 133 infection in Beijing, China. Cao et al ever investigated the rate of macrolide resistance in 134 outpatients, but the patients in his study were adults and adolescents (aged≥14 years) 20 . Ishiguro 135 et al showed that the rate of macrolide resistance in pediatric outpatients in Hokkaido, Japan was 136 44.3%. However, the sample size in his study was small, there were only 31 pediatric outpatients 137 
